PPARG and colitis: Studies have shown that PPAR-γ is upregulated in colitis models, and clinical data suggest reduced PPAR-γ expression in ulcerative colitis (UC) patients compared to in healthy controls, making PPAR-γ an attractive therapeutic target for restoring intestinal homeostasis [36,37].